ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HYL Hyloris Pharmaceuticals SA

11.70
0.00 (0.00%)
Last Updated: 06:30:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Hyloris Pharmaceuticals SA EU:HYL Euronext Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.70 11.80 13.00 0.00 06:30:00

EMM Disclosure

23/07/2003 1:37pm

UK Regulatory


RNS Number:8724N
Teather & Greenwood Ld
23 July 2003


EMM DISCLOSURE
                                                             FORM 38.5 (SUMMARY)

Lodge with a RIS and the Takeover Panel.  Use a separate form for each class of
securities in which dealings have been made.


CONNECTED EXEMPT MARKET- MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS

Name of EMM


TEATHER & GREENWOOD LIMITED



Date of disclosure


23 JULY 2003



Contact name


JASON STIMPSON



Telephone number


020 7426 7714



Please see attached disclosure of dealings under Rule 38.5 in the securities
of the following companies:


HAMLEYS PLC





If the attached Rule 38.5 disclosure is to amend a previous disclosure, please
state which element(s) of previous disclosure was incorrect:






In the case of option business or dealings in derivatives full details should be
given on a separate sheet so that the nature of the dealings can be fully
understood. For options this should include the number of securities under
option, the exercise period (or in the case of exercise, the exercise date), the
exercise price and any option money paid or received. For derivatives this
should include, at least, the number of reference securities to which they
relate (when relevant), the maturity date (or if applicable the closing out
date) and the reference price.

For full details of the disclosure requirements see Rules 8 and 38 of the Code.
If in doubt contact the Monitoring Section of the Panel, Tel. No: 020 7638 0129.
Email: monitoring@disclosure.org.uk




                                                                       FORM 38.5

CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS



Dealing in (name of company)


HAMLEYS PLC



Class of security


ORD 5 5/9p



Date of disclosure


23  JULY 2003



Date of dealing


22 JULY 2003



Name of EMM


TEATHER & GREENWOOD LIMITED



Name of offeree/offeror with whom connected


HAMLEYS PLC



Total number of securities purchased


3000



Highest price paid* (GBP)


251p



Lowest price paid*


251p



Total number of securities sold




Highest price received*




Lowest price received*


*Currency must be stated


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

EMMSEIFEDSDSEDW

1 Year Hyloris Pharmaceuticals Chart

1 Year Hyloris Pharmaceuticals Chart

1 Month Hyloris Pharmaceuticals Chart

1 Month Hyloris Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock